Stockscreener 앱 받기
29.79
0.63%
-0.19
시간 외 거래:
29.76
-0.03
-0.10%
Biolife Solutions Inc 주식(BLFS)의 최신 뉴스
BLFS|BioLife Solutions Inc|Price:29.950|Chg%:-0.030 - TradingKey
BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BLFS|BioLife Solutions Inc|Price:29.980|Chg%:-0.790 - TradingKey
BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioLife Solutions, Inc. Revenue Breakdown – GETTEX:BJX1 - TradingView
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc.BLFS - The Malone Telegram
Repligen Corporation to Acquire BioLife Solutions for $1.5 Billion, Boosting Cell Therapy Market Presence - Kalkine Media
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal - Stock Titan
BioLife Solutions Inc (BLFS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo Finance
BIOLIFE SOLUTIONS INC : JEFFERIES CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $31 FROM $30 - Bitget
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition - Sahm
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout - TradingView
Jefferies Downgrades BioLife Solutions to Hold From Buy, Adjusts Price Target to $31 From $30 - Moomoo
BIOLIFE SOLUTIONS INC : TD COWEN CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $31 FROM $33 - Bitget
Bothell firm fetches $1.5 billion in acquisition by Massachusetts company - The Business Journals
Repligen Corporation (RGEN) BioLife Solutions, Inc.,M&A CallSlideshow (NASDAQ:RGEN) 2026-07-23 - Seeking Alpha
Repligen to Acquire BioLife Solutions for $1.5 Billion, Expanding Leadership in Cell Therapy Market - Minichart
BioLife Solutions Inc (BLFS) Stock Up 6.8% but GF Value Says Ove - GuruFocus
BioLife Solutions Cut to Hold From Buy by Lake Street - Moomoo
BioLife Solutions to Be Acquired by Repligen Corporation - TipRanks
Repligen to Acquire Bothell's BioLife Solutions in $1.5B Deal - 425business.com
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per Share - TradingView
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-stock deal - Stock Titan
Repligen to Acquire BioLife Solutions for $11.25 per Share Plus Stock, Enhancing Cell Processing Capabilities - Kalkine Media
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach - Yahoo Finance
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS) - PR Newswire
Repligen targets cell therapy expansion as Waltham firm inks $1.5 billion acquisition - The Business Journals
BioLife Solutions downgraded to Hold amid $1.5B Repligen acquisition and shareholder fairness probe - Pluang
Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal, Expanding Into Cell Therapy - finance.biggo.com
Repligen Corporation entered into an agreement and plan of merger to acquire BioLife Solutions, Inc. for approximately $1.6 billion. - marketscreener.com
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
Repligen buys BioLife Solutions for $1.5 billion - grafa.com
Repligen to buy BioLife Solutions for USD 1.5 billion in cash-and-stock deal - Bitget
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife - Reuters
Repligen Announces Acquisition of BioLife Solutions in $11.25 Per Share Cash and Stock Deal - Kalkine Media
Repligen to Acquire BioLife Solutions in Cash and Stock Merger Valued at $11.25 Per Share - Kalkine Media
What's Going on With Repligen Stock Wednesday?Repligen (NASDAQ:RGEN), BioLife Solutions (NASDAQ:BLFS) - Benzinga
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders - New Castle News
Repligen Corp To Acquire BioLife Solutions Transcript - GuruFocus
Repligen to acquire BioLife Solutions for $1.5 billion By Investing.com - Investing.com Nigeria
Repligen to acquire BioLife Solutions for $1.5 billion - Investing.com
Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal - marketscreener.com
BioLife SolutionsDeal Expected to Be Accre - Moomoo
Press Release: Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities With Market Leading Biopreservation Media - Moomoo
Goodwin Advises Repligen In Acquisition Of BioLife Solutions For Approximately $1.5 Billion - Mondaq
Form 4 BioLife Solutions Inc For: 21 July By Investing.com - Investing.com Nigeria
BioLife Solutions (NASDAQ: BLFS) CTO has 275 shares withheld for RSU taxes - Stock Titan
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in cash and stock merger - Stock Titan
A Look at BioLife Solutions Inc (BLFS) After 3.7% Decline -- GF Value $28.86 vs Price $29.11 - GuruFocus
Biolife Solutions stock hits 52-week high at 30.03 USD By Investing.com - Investing.com South Africa
Biolife Solutions stock hits 52-week high at 30.03 USD - Investing.com
Form 4 BioLife Solutions Inc For: 13 July By Investing.com - Investing.com Canada
BioLife Solutions (BLFS) CFO has 844 shares withheld for RSU taxes - Stock Titan
BioLife Solutions (NASDAQ: BLFS) EVP has 516 shares withheld for taxes - Stock Titan
BioLife Solutions (BLFS) Holds Near Support Amid ConsolidationWeekly Profile - DonanımHaber
3 Stocks That May Be Trading At A Discount Of Up To 45.8% Below Intrinsic Value Estimates - simplywall.st
How Broad Russell Value Index Inclusion Will Impact BioLife Solutions (BLFS) Investors - simplywall.st
BLFSBiolife Solutions Inc Options - Finviz
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know - MSN
Q3 2025 BioLife Solutions Inc Earnings Call Transcript - GuruFocus
Daily Brief Health Care: Blue Jet Healthcare Ltd, BioLife Solutions Inc, Imugene Ltd, Inmode , Medinet Co Ltd, Merck & Co and more - Smartkarma
BioLife Shares Jump As Takeover Buzz Exposes A Bigger Biotech Trend! - Smartkarma
Does BioLife Solutions’ (BLFS) Russell Value Index Debut Recast Its Cell and Gene Therapy Narrative? - simplywall.st
BioLife Solutions, Inc.(NasdaqCM:BLFS) added to Russell Microcap Value Benchmark Index - marketscreener.com
0.62%
0.03%
자본화:
|
볼륨(24시간):